- Home
- NCPL vs NUWE Comparison
NCPL vs NUWE Comparison
Compare NCPL & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCPL
- NUWE
- Stock Information
- Founded
- NCPL 1984
- NUWE 1999
- Country
- NCPL United States
- NUWE United States
- Employees
- NCPL N/A
- NUWE N/A
- Industry
- NCPL Investment Managers
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NCPL Finance
- NUWE Health Care
- Exchange
- NCPL Nasdaq
- NUWE Nasdaq
- Market Cap
- NCPL 4.3M
- NUWE 3.9M
- IPO Year
- NCPL N/A
- NUWE N/A
- Fundamental
- Price
- NCPL $4.08
- NUWE $0.27
- Analyst Decision
- NCPL
- NUWE Strong Buy
- Analyst Count
- NCPL 0
- NUWE 1
- Target Price
- NCPL N/A
- NUWE $17.00
- AVG Volume (30 Days)
- NCPL 568.1K
- NUWE 30.6M
- Earning Date
- NCPL 07-28-2025
- NUWE 08-12-2025
- Dividend Yield
- NCPL N/A
- NUWE N/A
- EPS Growth
- NCPL N/A
- NUWE N/A
- EPS
- NCPL N/A
- NUWE N/A
- Revenue
- NCPL $812,612.00
- NUWE $8,787,000.00
- Revenue This Year
- NCPL N/A
- NUWE $6.53
- Revenue Next Year
- NCPL $101.16
- NUWE $51.63
- P/E Ratio
- NCPL N/A
- NUWE N/A
- Revenue Growth
- NCPL N/A
- NUWE N/A
- 52 Week Low
- NCPL $1.41
- NUWE $0.21
- 52 Week High
- NCPL $11.90
- NUWE $8.23
- Technical
- Relative Strength Index (RSI)
- NCPL 68.27
- NUWE 26.67
- Support Level
- NCPL $3.82
- NUWE $0.21
- Resistance Level
- NCPL $5.75
- NUWE $0.32
- Average True Range (ATR)
- NCPL 0.63
- NUWE 0.08
- MACD
- NCPL 0.15
- NUWE -0.01
- Stochastic Oscillator
- NCPL 53.87
- NUWE 9.98
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.